Product
CHOP + CD4
1 clinical trial
1 drug
1 indication
Indication
T-cell LymphomaDrug
CHOPClinical trial
A Multicentre Open-label Dose Escalation Tiral of Zanolimumab in Combination With CHOP Chemotherapy in Patients With CD4 Positive Non-cutaneous Peripheral T-cell Lymphoma With Nodal Involvement.Status: Terminated, Estimated PCD: 2008-10-01